Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial

NCT02394652 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02394652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02394652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
May 21, 2015
Completion date
January 12, 2021
Enrollment
16 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, carcinoma, adenosquamous, squamous cell carcinoma, uterine cervical neoplasms